Stibbe advises on the equity offering of ProQR

Matter
NL Law
Expertise
Capital Markets Healthcare and Life Sciences
Stibbe advised the joint bookrunners Citigroup, Evercore ISI and RBC Capital Markets and the co-managers on the $104.1 million equity offering of ProQR Therapeutics N.V. ("ProQR"). 
Amsterdam

ProQR is a biopharmaceutical company creating transformative RNA medicines for the treatment of severe genetic rare diseases and listed on Nasdaq.

Key contact(s)

Team